Genomic and biological characterization of exon 4 KRAS mutations in human cancer

Mutations in RAS proteins occur widely in human cancer. Prompted by confirmation of KRAS mutation as a predictive biomarker of response to EGFR targeted therapies, limited clinical testing for RAS pathway mutations has recently been adopted. We performed a multiplatform genomic analysis to character...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Janakiraman, Manickam, Vakiani, Efsevia, Zeng, Zhaoshi, Pratilas, Christine A., Taylor, Barry S., Chitale, Dhananjay, Halilovic, Ensar, Wilson, Manda, Huberman, Kety, Filho, Julio Cezar Ricarte, Persaud, Yogindra, Levine, Douglas A., Fagin, James A., Jhanwar, Suresh C., Mariadason, John M., Lash, Alex, Ladanyi, Marc, Saltz, Leonard B., Heguy, Adriana, Paty, Philip B., Solit, David B.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2943514/
https://ncbi.nlm.nih.gov/pubmed/20570890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-10-0192
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky